1. Home
  2. PAAS vs MEDP Comparison

PAAS vs MEDP Comparison

Compare PAAS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pan American Silver Corp.

PAAS

Pan American Silver Corp.

HOLD

Current Price

$44.19

Market Cap

18.0B

Sector

N/A

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$543.83

Market Cap

13.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAAS
MEDP
Founded
1994
1992
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.0B
13.4B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
PAAS
MEDP
Price
$44.19
$543.83
Analyst Decision
Strong Buy
Hold
Analyst Count
4
12
Target Price
$47.00
$465.18
AVG Volume (30 Days)
5.8M
277.0K
Earning Date
11-12-2025
10-22-2025
Dividend Yield
1.04%
N/A
EPS Growth
N/A
25.36
EPS
1.73
14.32
Revenue
$3,254,800,000.00
$2,358,373,000.00
Revenue This Year
$27.28
$21.48
Revenue Next Year
$21.01
$11.90
P/E Ratio
$29.46
$38.28
Revenue Growth
21.75
13.88
52 Week Low
$19.80
$250.05
52 Week High
$46.60
$626.26

Technical Indicators

Market Signals
Indicator
PAAS
MEDP
Relative Strength Index (RSI) 65.76 36.48
Support Level $43.44 $530.96
Resistance Level $46.60 $626.26
Average True Range (ATR) 1.84 18.24
MACD 0.58 -8.14
Stochastic Oscillator 79.93 17.60

Price Performance

Historical Comparison
PAAS
MEDP

About PAAS Pan American Silver Corp.

Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: